Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Mark

Showing results (281-290 of 331) with videos related to

Pageof 34
Sort By:
International Journal of Cardiology|January 29, 2014
Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?Sana M Al-Khatib, Joo Y Han, Rex Edwards, et al.
Open Heart|March 14, 2018
Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathyRalph A H Stewart, Dominika Szalewska, Amanda Stebbins, et al.
Circulation|March 9, 2022
Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIADaniel B Mark, John A Spertus, Robert Bigelow, et al.
Circulation. Cardiovascular Quality and Outcomes|February 12, 2015
Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trialsPaul L Hess, Sana M Al-Khatib, Joo Y Han, et al.
Journal of the American College of Cardiology|November 24, 2018
Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart FailureDaniel B Mark, Patricia A Cowper, Kevin J Anstrom, et al.
Journal of the American College of Cardiology|August 31, 2019
Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection FractionJames L Januzzi, Tariq Ahmad, Hillary Mulder, et al.
Journal of the American College of Cardiology|February 7, 2006
The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) StudyLeslee J Shaw, Marian B Olson, Kevin Kip, et al.
Journal of Cardiovascular Electrophysiology|July 27, 2017
Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT IIEmily P Zeitler, Sana M Al-Khatib, Daniel J Friedman, et al.
Journal of the American College of Cardiology|July 15, 2017
Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical TrialJoseph G Rogers, Chetan B Patel, Robert J Mentz, et al.
Circulation|April 9, 2017
Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)Udo Hoffmann, Maros Ferencik, James E Udelson, et al.
Pageof 34

Showing results (281-290 of 331) with videos related to

Sort By:
Pageof 34
International Journal of Cardiology|January 29, 2014
Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?Sana M Al-Khatib, Joo Y Han, Rex Edwards, et al.
Open Heart|March 14, 2018
Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathyRalph A H Stewart, Dominika Szalewska, Amanda Stebbins, et al.
Circulation|March 9, 2022
Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIADaniel B Mark, John A Spertus, Robert Bigelow, et al.
Circulation. Cardiovascular Quality and Outcomes|February 12, 2015
Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trialsPaul L Hess, Sana M Al-Khatib, Joo Y Han, et al.
Journal of the American College of Cardiology|November 24, 2018
Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart FailureDaniel B Mark, Patricia A Cowper, Kevin J Anstrom, et al.
Journal of the American College of Cardiology|August 31, 2019
Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection FractionJames L Januzzi, Tariq Ahmad, Hillary Mulder, et al.
Journal of the American College of Cardiology|February 7, 2006
The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) StudyLeslee J Shaw, Marian B Olson, Kevin Kip, et al.
Journal of Cardiovascular Electrophysiology|July 27, 2017
Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT IIEmily P Zeitler, Sana M Al-Khatib, Daniel J Friedman, et al.
Journal of the American College of Cardiology|July 15, 2017
Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical TrialJoseph G Rogers, Chetan B Patel, Robert J Mentz, et al.
Circulation|April 9, 2017
Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)Udo Hoffmann, Maros Ferencik, James E Udelson, et al.
Pageof 34